Piché A - Search Results

1

Gene therapy strategies for AIDS-related malignancies.

Curiel TJ, Piché A, Kasono K, Curiel DT. Curiel TJ, et al. Among authors: piche a. Gene Ther. 1997 Dec;4(12):1284-8. doi: 10.1038/sj.gt.3300538. Gene Ther. 1997. PMID: 9472551 Review.

2

Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.

Piché A, Kasono K, Johanning F, Curiel TJ, Curiel DT. Piché A, et al. Gene Ther. 1998 Sep;5(9):1171-9. doi: 10.1038/sj.gt.3300706. Gene Ther. 1998. PMID: 9930317

3

Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.

Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Suzuki T, et al. Among authors: piche a. Biochem Biophys Res Commun. 1998 Nov 27;252(3):686-90. doi: 10.1006/bbrc.1998.9685. Biochem Biophys Res Commun. 1998. PMID: 9837767

4

Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.

Kasono K, Heike Y, Xiang J, Piché A, Kim HG, Kim M, Hagiwara M, Nawrath M, Moelling K, Curiel DT. Kasono K, et al. Among authors: piche a. Cancer Gene Ther. 2000 Jan;7(1):151-9. doi: 10.1038/sj.cgt.7700117. Cancer Gene Ther. 2000. PMID: 10678368

5

Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.

Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piché A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Rancourt C, et al. Among authors: piche a. Clin Cancer Res. 1998 Oct;4(10):2455-61. Clin Cancer Res. 1998. PMID: 9796978

6

Functional knock-out of c-myb by an intracellular anti-c-Myb single-chain antibody.

Kasono K, Piché A, Xiang J, Kim HG, Bilbao G, Johanning F, Nawrath M, Moelling K, Curiel DT. Kasono K, et al. Among authors: piche a. Biochem Biophys Res Commun. 1998 Oct 9;251(1):124-30. doi: 10.1006/bbrc.1998.9259. Biochem Biophys Res Commun. 1998. PMID: 9790918

7

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Among authors: piche a. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

8

Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7.

Piché A, Grim J, Rancourt C, Gómez-Navarro J, Reed JC, Curiel DT. Piché A, et al. Cancer Res. 1998 May 15;58(10):2134-40. Cancer Res. 1998. PMID: 9605757

9

Gene therapy to overcome drug resistance in cancer: targeting key regulators of the apoptotic pathway.

Piché A, Rancourt C. Piché A, et al. Curr Gene Ther. 2001 Nov;1(4):317-24. doi: 10.2174/1566523013348382. Curr Gene Ther. 2001. PMID: 12109059 Review.

10

Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.

Rancourt C, Bergeron C, Lane D, Garon G, Piché A. Rancourt C, et al. Among authors: piche a. Cytotherapy. 2003;5(6):509-22. doi: 10.1080/14653240310003620. Cytotherapy. 2003. PMID: 14660047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters